Annual Drug Patent Expirations for BIJUVA
Bijuva is a drug marketed by Mayne Pharma and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting this drug.
Drug patent litigation for BIJUVA.
This drug has one hundred and sixty-three patent family members in twenty-one countries.
The generic ingredient in BIJUVA is estradiol; progesterone. Two suppliers are listed for this compound. Additional details are available on the estradiol; progesterone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
